India News | Health Min Aware of Media Reports About 'some' Controversy Around Covaxin Supply to Brazil: Govt
Get latest articles and stories on India at LatestLY. The health ministry is aware of media reports about "some" controversy around contracts and regulatory approvals for supply of Covaxin to Brazil, but this relates exclusively to an agreement between a commercial entity Bharat Biotech and another country, Lok Sabha was told on Friday.
New Delhi, Jul 23 (PTI) The health ministry is aware of media reports about "some" controversy around contracts and regulatory approvals for supply of Covaxin to Brazil, but this relates exclusively to an agreement between a commercial entity Bharat Biotech and another country, Lok Sabha was told on Friday.
Minister of State for Health Bharati Pravin Pawar stated this in a written reply to a question on whether the government has received reports about a "huge" controversy between Bharat Biotech and the Brazilian government over the supply of Rs 2 crore worth of anti-Covid vaccine Covaxin.
"The health ministry is aware of media reports of some controversy around contracts and regulatory approvals for supply of Covaxin to Brazil. This, however, relates exclusively to an agreement between a commercial entity i.e. M/s Bharat Biotech and a foreign country," she said.
(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)